Everyone would benefit if researchers did more to make participants feel part of a study

Quick Read

Participants in medical research are more empowered than ever to influence the design and outcomes of experiments. Now, researchers are trying to keep up

Quick Read

Health officials are preparing to launch a clinical trial designed to test whether experimental Ebola therapies improve patients’ chances of survival in the outbreak in the Democratic Republic of the Congo — a landmark moment in the world’s efforts to respond to this and future crises

Quick Read

For Dr. Piero Anversa, the fall from scientific grace has been long, and the landing hard

Quick Read

The general theme of digital health care is easy to grasp — maybe too easy. Somewhere, right now, a hopeful CEO is making a pitch to a potential investor about how its new digital product or service will transform health care and improve outcomes, reduce costs, and save time. The story works

Quick Read

A landmark report says pregnant and lactating women should be included in clinical trials. It’s unclear what the chances are that DHHS will agree with the recommendations in the report, but either way, says Ruth Faden, founder of the Johns Hopkins Berman Institute of Bioethics, “the very existence of the report is huge.”

Quick Read

A trial enrolling new patients resembles “an experiment that would be conducted on laboratory animals,” one advocacy group said

Quick Read

A ProPublica analysis found that black people and Native Americans are under-represented in clinical trials of new drugs, even when the treatment is aimed at a type of cancer that disproportionately affects them

Quick Read